Education
About Us
Working with TipRanks
Follow Us
project $XM 202X - New Portfolio
kamga
project $XM 202XIndividual Investor
Ranked #45,661 out of 824,099 TipRanks' Investors
Success Rate
100 out of 144
profitable transactions
profitable transactions
Average Return
44.58%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 0.17%
6-Month Return▲ 109.27%
12-Month Return▲ 128.51%
YTD Return▲ 132.49%
Total Return▲ 1440.32%
Best Trade
Bio
stock picker with very limited experience on market knowledge...
Performance
34.31%0-34.31%
▼ 6.38%
▼ 5.57%
▲ 2.69%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 5.68%
Apr 2025
▲ 11.63%
▲ 6.28%
▼ 4.41%
May 2025
▲ 9.25%
▲ 5.14%
▲ 34.31%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 27.21%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 2.44%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 12.09%
Sep 2025
▲ 4.03%
▼ 0.27%
▲ 2.60%
Oct 2025
▼ 6.38%▼ 5.57%▲ 2.69%
▲ 0.80%▼ 0.87%▲ 5.68%
▲ 11.63%▲ 6.28%▼ 4.41%
▲ 9.25%▲ 5.14%▲ 34.31%
▲ 7.60%▲ 2.30%▲ 27.21%
▲ 2.76%▲ 2.05%▲ 2.44%
▲ 12.88%▲ 3.56%▲ 12.09%
▲ 4.03%▼ 0.27%▲ 2.60%
Recent Activity
Urogen Pharma
10.83%
▲ 331.30%
3
Sell
Oct 16, 2025
Ocular Therapeutix
0%
▲ 28.37%
8
Sell
Oct 08, 2025
iShares Silver Trust
11.44%
▲ 59.40%
2
Sell
Oct 08, 2025
Opendoor Technologies
0.22%
▲ 124.10%
5
Sell
Oct 08, 2025
Datavault AI
0.65%
▲ 3.57%
2
Buy
Oct 08, 2025
reAlpha Tech Corp.
0.03%
▼ 25.86%
1
Open
Oct 08, 2025
Lithium Americas Corp.
0%
▼ 3.55%
1
Open
Oct 01, 2025
XPeng, Inc. ADR
0%
▲ 6.32%
2
Sell
Sep 23, 2025
Scilex Holding Company
0.78%
▲ 39.87%
2
Buy
Sep 23, 2025
Archer Aviation
0%
▲ 32.08%
1
Open
Sep 07, 2025
Larimar Therapeutics
0%
▲ 12.90%
1
Open
Aug 13, 2025
VistaGen Therapeutics
0%
▲ 38.23%
1
Open
Aug 13, 2025
Figma, Inc. Class A
0%
▼ 30.61%
1
Open
Aug 13, 2025
Circle Internet Group, Inc. Class A
0%
▼ 17.41%
1
Open
Aug 13, 2025
Palladyne AI Corp
0%
▲ 3.40%
1
Open
Aug 04, 2025
Cardiff Oncology
6.66%
▼ 41.29%
1
Open
Jul 28, 2025
Axsome Therapeutics
―
▲ 17.31%
7
Close
May 03, 2025
Galectin Therapeutics
30.36%
▲ 116.01%
14
Buy
May 03, 2025
Visa
―
▲ 46.89%
5
Close
May 03, 2025
TG Therapeutics
37.97%
▲ 172.36%
16
Buy
May 03, 2025